Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isochroman Compounds. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112794837A details a novel selenium-mediated cyclization for isochroman intermediates, offering mild conditions and high yields for pharmaceutical manufacturing.
Patent CN112794837B reveals a high-yield isochroman synthesis using TPSCA. This method offers mild conditions and cost reduction in pharmaceutical intermediate manufacturing.